The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy.
We compared two interferon gamma release assays (IGRAs), QuantiFERON-TB Gold In-Tube (QFT-GIT) and T-SPOT.TB, for diagnosis of latent tuberculosis infection (LTBI) in patients before and while receiving tumor necrosis factor (TNF)-α antagonist therapy. This study evaluated the significance of sensit...
Main Authors: | Yu Jung Jung, Hye In Woo, Kyeongman Jeon, Won-Jung Koh, Dong Kyoung Jang, Hoon Suk Cha, Eun Mi Koh, Nam Yong Lee, Eun-Suk Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4608840?pdf=render |
Similar Items
-
QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.
by: Hyun Lee, et al.
Published: (2015-01-01) -
Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active <i>Mycobacterium tuberculosis</i> Infections in Tertiary Care Setting?
by: Jaewan Jung, et al.
Published: (2021-03-01) -
Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist
by: Ilaria Sauzullo, et al.
Published: (2010-06-01) -
Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
by: Tan N Doan, et al.
Published: (2017-01-01) -
Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection
by: Eun Hye Lee, et al.
Published: (2017-07-01)